The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Abstract
BACKGROUND: The development of tumor necrosis factor alpha (TNF-alpha) antagonists has made it feasible to investigate the role of this cytokine in refractory asthma. METHODS: We measured markers of TNF-alpha activity on peripheral-blood monocytes in 10 patients with refractory asthma, 10 patients with mild-to-moderate asthma, and 10 control subjects. We also investigated the effects of treatment with the soluble TNF-alpha receptor etanercept (25 mg twice weekly) in the patients with refractory asthma in a placebo-controlled, double-blind, crossover pilot study. RESULTS: As compared with patients with mild-to-moderate asthma and controls, patients with refractory asthma had increased expression of membrane-bound TNF-alpha, TNF-alpha receptor 1, and TNF-alpha-converting enzyme by peripheral-blood monocytes. In the clinical trial, as compared with placebo, 10 weeks of treatment with etanercept was associated with a significant increase in the concentration of methacholine required to provoke a 20 percent decrease in the forced expiratory volume in one second (FEV1) (mean difference in doubling concentration changes between etanercept and placebo, 3.5; 95 percent confidence interval, 0.07 to 7.0; P=0.05), an improvement in the asthma-related quality-of-life score (by 0.85 point; 95 percent confidence interval, 0.16 to 1.54 on a 7-point scale; P=0.02), and a 0.32-liter increase in post-bronchodilator FEV1 (95 percent confidence interval, 0.08 to 0.55; P=0.01). CONCLUSIONS: Patients with refractory asthma have evidence of up-regulation of the TNF-alpha axis. (ClinicalTrials.gov number, NCT00276029.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationMast-Cell Infiltration of Airway Smooth Muscle in Asthma
Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., & Pavord, I. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012705 · Cited by 1,241
Self-citationWENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Kriegler, M., Perez, C., DeFay, K., Albert, I., & Lu, S. D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,102
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909
Measuring Quality of Life in Asthma
Juniper, E. F., Guyatt, G. H., Ferrie, P. J., & Griffith, L. E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.832 · Cited by 887
Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H., & Holgate, S. T. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179909 · Cited by 830
Self-citationThe ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
Cytokines in symptomatic asthma airways
Broide, D. H., Lotz, M., Cuomo, A. J., Coburn, D. A., Federman, E. C., & Wasserman, S. I. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90218-q · Cited by 736
Kharitonov, S., Alving, K., & Barnes, P. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10071683 · Cited by 664
Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., & Loetscher, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3127 · Cited by 661
Howarth, P. H. (2005) · Thorax · doi:10.1136/thx.2005.045260 · Cited by 495
The active form of tumor necrosis factor is a trimer.
Smith, R. A., & Baglioni, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48183-5 · Cited by 429
Costs of asthma according to the degree of severity
Serra-Batlles, J., Plaza, V, Morejon, E., Comella, A., & Brugues, J. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061322 · Cited by 387
Thomas, P. S., Yates, D. H., & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599866 · Cited by 360
Tumor Necrosis Factor Causes Bronchial Hyperresponsiveness in Rats
Kips, J. C., Tavernier, J., & Pauwels, R. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.2_pt_1.332 · Cited by 284
Berry, M., Hargadon, B., Morgan, A., Shelley, M., Richter, J., Shaw, D., Green, R. H., Brightling, C., Wardlaw, A. J., & Pavord, I. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00132404 · Cited by 220
Self-citationFranchimont, D., Martens, H., Hagelstein, M.-T., Louis, E., Dewe, W., Chrousos, G. P., Belaiche, J., & Geenen, V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5931 · Cited by 218
BUSSE, W., ELIAS, J., SHEPPARD, D., & BANKS-SCHLEGEL, S. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9902064 · Cited by 202
Zheng, Y., Saftig, P., Hartmann, D., & Blobel, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403193200 · Cited by 158
Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation
Rouhani, F. N., Meitin, C. A., Kaler, M. M., Hilligoss, D. M., Stylianou, M. P., & Levine, S. J. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.02.031 · Cited by 66
Franchimont, D. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2834 · Cited by 57
Structure of human tumor necrosis factor .alpha. derived from recombinant DNA
Davis, J. M., Narachi, M. A., Alton, N. K., & Arakawa, T. (1987) · Biochemistry · doi:10.1021/bi00379a018 · Cited by 52
Marshall, B. G., Wangoo, A., Harrison, L. I., Young, D. B., & Shaw, R. J. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15d22.x · Cited by 32
Armstrong, L., THICKETT, D. R., Christie, S. J., Kendall, H., & Millar, A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.1.3728 · Cited by 31
Cited by
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Self-citationTNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Metadata
- Authors
- Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-02-16
- Volume
- 354
- Issue
- 7
- Pages
- 697-708
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2170599998
- Cited by
- 826
- References
- 25
- FWCI
- 59.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.